Current role
Biotechnology · Healthcare
Board Member
2023-12-27–present
Barbara Bodem
Board Member
Biomarin Pharmaceutical Inc (BMRN)Equibles does not estimate personal net worth.
Get an email with a short summary when Biomarin Pharmaceutical Inc publishes a filing, an earnings call transcript or a press release.
Get BMRN alertsAbout Barbara Bodem
Barbara Bodem is recorded as Board Member at Biomarin Pharmaceutical Inc (BMRN) since December 27, 2023. Biomarin Pharmaceutical Inc reported in an 8-K filed December 20, 2023 that Barbara Bodem was appointed independent director, effective December 27, 2023. Biomarin Pharmaceutical Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Biomarin Pharmaceutical Inc includes Alexander Hardy (CEO and Board Member), Richard A. Meier (Chairman), Brian Mueller (CFO) and 7 others.
“On December 20, 2023, the size of the Board was expanded from 12 to 15 members in order to allow for the Board to appoint each of Ms. Bodem, Dr. Countouriotis and Mr. Enyedy to serve as a member of the Board, effective on December 27, 2023.”
Affiliation history
-
Current
2023-12-27–present
Company network
Leadership on record at Biomarin Pharmaceutical Inc
- Alexander Hardy CEO, Board Member
- Richard A. Meier Chairman
- Brian Mueller CFO
- Daniel Spiegelman CFO
- Dr. C. Greg Guyer CTO
- G. Eric Davis General Counsel
- Andrea Acosta Chief Accounting Officer
- Rashmi Ramchandani Chief Accounting Officer
- Athena Countouriotis Board Member
- Barbara W. Bodem Board Member